Henry Schein (NASDAQ:HSIC) traded with a cut of -1.14 points or -0.65% at $173.58 per share. As per the last available information, the stock aggregated $16.46 million in upticks and $2.74 million in downticks, keeping the net money flow capped at $13.72 million. The up/down ratio was found to be 6.01. For the week, the shares have seen a change of -2.68% in the share price.A block trade of $13.67 million in upticks and $0 million in downticks also took place during the day. The up/down ratio for the block stood at 0. The net money flow for this transaction was $13.67 million.
Henry Schein, Inc. has dropped 3.06% in the last five trading days, however, the shares have posted positive gains of 1.14% in the last 4 weeks. Henry Schein, Inc. is up 3.15% in the last 3-month period. Year-to-Date the stock performance stands at 9.3%.
Currently the company Insiders own 1.27% of Henry Schein shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -15.37% . Institutional Investors own 96.38% of Henry Schein shares. During last six month period, the net percent change held by insiders has seen a change of -14.16%. . On the companys insider trading activities,The director officer (EVP, Chief Admin. Officer) of Henry Schein Inc, Benjamin Gerald A sold 9,991 shares at $175.07 on June 2, 2016. The Insider selling transaction had a total value worth of $1,749,124. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Henry Schein (NASDAQ:HSIC) witnessed a decline in the market cap on Friday as its shares dropped 1.04% or 1.81 points. After the session commenced at $174.79, the stock reached the higher end at $174.79 while it hit a low of $171.81. With the volume soaring to 584,705 shares, the last trade was called at $172.9. The company has a 52-week high of $180.98. The company has a market cap of $14,189 million and there are 82,066,386 shares in outstanding. The 52-week low of the share price is $126.17.
Henry Schein, Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins, among others. The Companys global technology and value-added services segment provides software, technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.